about
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug deliveryA review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesStrategies to Overcome Heparins' Low Oral BioavailabilityLong-term delivery of protein therapeuticsMicro/nanofabricated platforms for oral drug deliveryEnhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.Clinical studies with oral lipid based formulations of poorly soluble compoundsEnhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow AImprovement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancerPreparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex.Atomic force microscopy as analytical tool to study physico-mechanical properties of intestinal cells.Nanosuspensions: a promising drug delivery strategy.An overview of the evidence and mechanisms of herb-drug interactions.Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation EnhancerTherapeutic applications of hydrogels in oral drug delivery.Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levelsZonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayersDendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Progress in absorption enhancers based on tight junction.Natural and synthetic polymers as inhibitors of drug efflux pumps.A novel perspective and approach to intestinal octreotide absorption: sinomenine-mediated reversible tight junction opening and its molecular mechanism.Safety concerns over the use of intestinal permeation enhancers: A mini-reviewBlock copolymer micelles as nanocontainers for controlled release of proteins from biocompatible oil phases.Zanamivir oral delivery: enhanced plasma and lung bioavailability in ratsExploring tight junction alteration using double fluorescent probe combination of lanthanide complex with gold nanoclustersPreparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex.Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization.Noninvasive delivery systems for peptides and proteins in osteoporosis therapy: a retroperspective.Protein and Peptide drug delivery: oral approaches.Conditioning the cochlea to facilitate survival and integration of exogenous cells into the auditory epithelium.Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.Diverse approaches for the enhancement of oral drug bioavailability.Targeting receptors, transporters and site of absorption to improve oral drug delivery.On the interaction of Clostridium perfringens enterotoxin with claudins.Absorption enhancers: applications and advancesExcipients with specialized functions for effective drug delivery.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
P2860
Q24616011-FE6183D4-5C15-4692-83B1-30513414C7FBQ26744008-A1F44153-440C-4974-AE33-CBC874BD7150Q26745571-637120F8-F790-4A59-8460-E6DE1AD39993Q26860505-E1E134BE-72E4-4BBD-B852-A531358DB398Q28083448-77E5EA4D-2BA0-4FAB-9D93-439E85096BF3Q33773083-BFB5E726-8603-4902-94ED-15868AC0A8BAQ34778043-16AAF4AA-D5C1-434F-AACF-AB5498AE0C59Q35071621-0AD1331A-4F54-496F-9B01-C11F166AA841Q35090489-A164FB8E-60DA-4AAC-B471-845A02540248Q35677172-DD5CBB0F-9AEB-4CAB-8B43-FB9EAA419B2BQ35704931-FBDC3DE5-0FAF-4A52-B092-961600CE922EQ35826447-F0CA6308-3608-46E9-A9AC-B3329129714EQ35919968-320A210A-CC02-4A71-8CDF-B4C37E9D51A7Q35941004-3679C225-66D9-400E-8ECC-66D43EF644E1Q35995914-31D34FFE-72D1-49CA-9B4A-325BB9DAB743Q36012148-4B2A8470-BD85-47B8-9E8D-1C258D4ABC64Q36015126-D1C6948E-3186-4F6E-A561-2104D38792F4Q36400343-52C670DD-C3BC-47B9-B6D5-203C1FD58228Q36493562-83DE8140-A5A1-4B50-B660-3498A45276D5Q36690711-0BABBD94-2CAF-407C-966D-FAD6014BE211Q36815936-E69CBB7D-390F-4EB2-ADEA-46E762B94C9FQ36951710-30E0AC5F-97C4-4445-9B52-B35EF58007A7Q37007446-0096BA15-E560-4873-A942-4B12AD6D1668Q37012940-ADD51746-FF1C-4BAC-9C24-37557F73DAF0Q37108055-9DEC29CE-5396-4F91-B73A-4851121F6458Q37145564-ED9ABEF6-2F3B-47A3-A91A-AA140A771F0FQ37215871-BC6614F8-A3EB-47C3-ADDF-380D36A8C642Q37234697-D9A18FDE-7D40-42E2-ACD4-419A000FDFABQ37436438-B77218AD-B89C-4093-B1CF-08F7FAF0F513Q37548416-21377630-A34E-4ADD-BDB5-E93A8C606A62Q37565676-4C90874F-F876-41E7-850F-A8F8A63D5DBBQ37666699-92A9DDB9-06FD-40DF-B0FE-74D2B6E94E2EQ37696023-3602538E-3C23-4268-830F-D6739949C00CQ37818332-9D841971-7795-4789-9EE7-8F186B9EE483Q37863645-84CC905A-1908-403F-81CE-2CCC83161D72Q37928909-ED48EFC0-C774-457E-BA96-A67DD3E288C9Q37954298-4CDCDD00-BEFE-4302-8B3B-29FA4F867966Q37959280-B9B13BE9-0307-47B8-B2BD-19F09EF51CBCQ37971124-E1E85255-E9C3-40AE-A62E-81BD066B6FD6Q37988960-5C95541A-0432-4902-893E-A969A4EBC564
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intestinal permeation enhancers.
@ast
Intestinal permeation enhancers.
@en
type
label
Intestinal permeation enhancers.
@ast
Intestinal permeation enhancers.
@en
prefLabel
Intestinal permeation enhancers.
@ast
Intestinal permeation enhancers.
@en
P1476
Intestinal permeation enhancers.
@en
P2093
P304
P356
10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J
P407
P577
2000-04-01T00:00:00Z